Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector

24 September 2019

The value added medicines sector group of Medicines for Europe […]

Read more

Ready to drive access to medicines

21 June 2019

Medicines for Europe is ready to engage with the EU […]

Read more

Committing to Global Health: Balancing Access and Sustainability key to success

13 June 2019

Global medicine manufacturers gathered in Warsaw this week to discuss […]

Read more

Huge European Parliament majority votes to adopt the SPC manufacturing waiver

17 April 2019

The European Parliament today voted overwhelmingly with 572 Members of […]

Read more

‘Together for Health’: Medicines for Europe launches election manifesto to deliver on equitable patient access

3 April 2019

Medicines for Europe has launched its vision for pharmaceutical policy […]

Read more

Major challenges in the Intellectual Property (IP) environment for pharmaceuticals debated at Medicines for Europe Legal Conference

27 March 2019

The SPC manufacturing waiver, which will put an end to […]

Read more

Joint Press Statement of the Inter Associations Initiative (IAI) Pharmaceuticals in the Environment Task Force (AESGP, EFPIA, Medicines for Europe) – European Union Strategic Approach to Pharmaceuticals in the Environment

12 March 2019

Open

Report calls for better environment to improve patient access to value added medicines

26 February 2019

A new report launched today lays out clear recommendations to […]

Read more

Medicines for Europe applauds compromise on SPC manufacturing waiver

14 February 2019

Today, the European Council, Parliament and Commission agreed a compromise […]

Read more

New safeguards for patient safety as Falsified Medicines Directive comes into force

8 February 2019

The EU Falsified Medicines Directive was adopted in 2011 to […]

Read more

Subscribe to our newsletter